4.7 Article

Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

期刊

METHODS
卷 77-78, 期 -, 页码 25-30

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymeth.2015.02.005

关键词

PTEN; Prostate cancer; Fresh tissue; Molecular biology

资金

  1. Ramon y Cajal award
  2. Basque Department of Industry, Tourism and Trade (Etortek), Health and Education [2012111086, PI2012-03]
  3. Marie Curie [277043]
  4. Movember Foundation [GAP1]
  5. ISCIII [PI10/01484, PI13/00031, PT13/0010/0052]
  6. ERC [336343]
  7. Spanish Association Against Cancer (AECC)
  8. Basque Government of education
  9. MICINN [PTA2011-5805-I]
  10. European Research Council (ERC) [336343] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

Prostate cancer is among the most frequent cancers in men, and despite its high rate of cure, the high number of cases results in an elevated mortality worldwide. Importantly, prostate cancer incidence is dramatically increasing in western societies in the past decades, suggesting that this type of tumor is exquisitely sensitive to lifestyle changes. Prostate cancer frequently exhibits alterations in the PTEN gene (inactivating mutations or gene deletions) or at the protein level (reduced protein expression or altered sub-cellular compartmentalization). The relevance of PTEN in this type of cancer is further supported by the fact that the sole deletion of PTEN in the murine prostate epithelium recapitulates many of the features of the human disease. In order to study the molecular alterations in prostate cancer, we need to overcome the methodological challenges that this tissue imposes. In this review we present protocols and methods, using PTEN as proof of concept, to study different molecular characteristics of prostate cancer. (C) 2015 Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance

Violeta Serra, Anderson T. Wang, Marta Castroviejo-Bermejo, Urszula M. Polanska, Marta Palafox, Andrea Herencia-Ropero, Gemma N. Jones, Zhongwu Lai, Joshua Armenia, Filippos Michopoulos, Alba Llop-Guevara, Rachel Brough, Aditi Gulati, Stephen J. Pettitt, Krishna C. Bulusu, Jenni Nikkila, Zena Wilson, Adina Hughes, Paul W. G. Wijnhoven, Ambar Ahmed, Alejandra Bruna, Albert Gris-Oliver, Marta Guzman, Olga Rodriguez, Judit Grueso, Joaquin Arribas, Javier Cortes, Cristina Saura, Alan Lau, Susan Critchlow, Brian Dougherty, Carlos Caldas, Gordon B. Mills, J. Carl Barrett, Josep V. Forment, Elaine Cadogan, Christopher J. Lord, Cristina Cruz, Judith Balmana, Mark J. O'Connor

Summary: Targeting the replication stress response is a valid therapeutic option to overcome PARPi resistance, providing new strategies for treating tumors such as breast and ovarian cancer.

CLINICAL CANCER RESEARCH (2022)

Article Multidisciplinary Sciences

Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression

Marco Sciacovelli, Aurelien Dugourd, Lorea Valcarcel Jimenez, Ming Yang, Efterpi Nikitopoulou, Ana S. H. Costa, Laura Tronci, Veronica Caraffini, Paulo Rodrigues, Christina Schmidt, Dylan Gerard Ryan, Timothy Young, Vincent R. Zecchini, Sabrina H. Rossi, Charlie Massie, Caroline Lohoff, Maria Masid, Vassily Hatzimanikatis, Christoph Kuppe, Alex Von Kriegsheim, Rafael Kramann, Vincent Gnanapragasam, Anne Y. Warren, Grant D. Stewart, Ayelet Erez, Sakari Vanharanta, Julio Saez-Rodriguez, Christian Frezza

Summary: Metabolic flexibility occurs during ccRCC progression, and the reprogramming of branched-chain amino acid catabolism and urea cycle allows for metabolic flexibility in renal cancer progression.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes

Ainara Cano, Mercedes Vazquez-Chantada, Javier Conde-Vancells, Aintzane Gonzalez-Lahera, David Mosen-Ansorena, Francisco J. J. Blanco, Karine Clement, Judith Aron-Wisnewsky, Albert Tran, Philippe Gual, Carmelo Garcia-Monzon, Joan Caballeria, Azucena Castro, Maria Luz Martinez-Chantar, Jose M. Mato, Huiping Zhu, Richard H. H. Finnell, Ana M. M. Aransay

Summary: Low serum folate levels are associated with metabolic associated fatty liver disease (MAFLD). The role of the folate transporter gene (SLC19A1) in lipid accumulation during the onset of MAFLD was assessed through genomic, transcriptomic, and metabolomic techniques. SNPs rs1051266 and rs3788200 were significantly associated with fatty liver development, and the lack of functional SLC19A1 affected gene regulation and lipid metabolism, leading to lipid droplet accumulation in hepatocytes.

BIOMEDICINES (2023)

Correction Oncology

Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts (vol 126, pg 122, 2022 )

F. Guffanti, M. F. Alvisi, A. Anastasia, F. Ricci, M. Chiappa, A. Llop-Guevara, V. Serra, R. Fruscio, A. Degasperi, S. Nik-Zainal, M. R. Bani, M. Lupia, R. Giavazzi, E. Rulli, G. Damia

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Metabolism in the tumor cell and beyond

Arkaitz Carracedo

Summary: The process of cellular transformation involves the acquisition of key features known as hallmarks of cancer, which are supported by molecular alterations and changes in the microenvironment. Cellular metabolism is a crucial link between a cell and its environment, and metabolic adaptation is an increasingly important research field in cancer biology.

MOLECULAR ONCOLOGY (2023)

Article Chemistry, Multidisciplinary

Machine Learning-Assisted High-Throughput SERS Classification of Cell Secretomes

Javier Plou, Pablo S. Valera, Isabel Garcia, David Vila-Liarte, Carlos Renero-Lecuna, Jesus Ruiz-Cabello, Arkaitz Carracedo, Luis M. Liz-Marzan

Summary: During the response to stress, damaged cells release metabolites and secretomes, which can be utilized in anticancer therapies and biomarker predictions. However, monitoring these processes is challenging, leading to the development of noninvasive secretome screening tools. Machine learning methods and microfluidic chips were used to identify secretome variations and classify cell death, allowing for faster implementation of surface-enhanced Raman scattering (SERS) into cell secretome classification.
Article Cell Biology

Tuberous Sclerosis Complex cell-derived EVs have an altered protein cargo capable of regulating their microenvironment and have potential as disease biomarkers

Muireann Ni Bhaoighill, Juan M. Falcon-Perez, Felix Royo, Andrew R. Tee, Jason P. Webber, Elaine A. Dunlop

Summary: This study investigates the role of extracellular vesicles (EVs) in modulating the tumor microenvironment and their impact on the development of TSC tumors. It shows that EVs secreted from TSC2-deficient cells contain a specific protein cargo that promotes cell viability, proliferation, and growth factor secretion in the tumor microenvironment. The study also demonstrates that rapamycin can alter the cargo of EVs and reduce their ability to promote cell proliferation.

JOURNAL OF EXTRACELLULAR VESICLES (2023)

Article Microbiology

Orally Administered Bifidobacterium adolescentis Diminishes Serum Glutamate Concentration in Mice

Felix Royo, Hector Tames, Guillermo Bordanaba-Florit, Diana Cabrera, Maria Azparren-Angulo, Clara Garcia-Vallicrosa, Abelardo Margolles, Lorena Ruiz, Patricia Ruas-Madiedo, Juan M. Falcon-Perez

Summary: This study used mice as a model and fed them with a bacterial strain of B. adolescentis that can degrade glutamate and convert it into GABA. The bacterium can survive in the gastric tract and the animals reduce their blood glutamate concentration over time. The results suggest that an oral diet with this probiotic-type bacteria could reduce the concentration of glutamate in the blood, providing a reference for clinical trial studies in patients with chronic diseases.

MICROBIOLOGY SPECTRUM (2023)

Review Biochemistry & Molecular Biology

The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer

Clara Garcia-Vallicrosa, Juan M. Falcon-Perez, Felix Royo

Summary: The human CERS2 gene encodes a protein called CERS2, which has been found to have antitumor effects in various types of cancer, but promotes tumor growth in adenocarcinoma. This review focuses on the influence of CERS2 in bladder cancer, including its structure, activity, and the miRNAs that regulate its expression. Mechanistically, CERS2 may act as an antitumor protein through the production of long-chain ceramides, interaction with vacuolar ATPase, and inhibition of mitochondrial fission. Additionally, the expression of CERS2 in bladder cancer and its association with disease progression are discussed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway

Jan Pencik, Cecile Philippe, Michaela Schlederer, Emine Atas, Matteo Pecoraro, Sandra Grund-Groeschke, Wen (Jess) Li, Amanda Tracz, Isabel Heidegger, Sabine Lagger, Karolina Trachtova, Monika Oberhuber, Ellen Heitzer, Osman Aksoy, Heidi A. Neubauer, Bettina Wingelhofer, Anna Orlova, Nadine Witzeneder, Thomas Dillinger, Elisa Redl, Georg Greiner, David D'Andrea, Johnny R. Ostman, Simone Tangermann, Ivana Hermanova, Georg Schaefer, Felix Sternberg, Elena E. Pohl, Christina Sternberg, Adam Varady, Jaqueline Horvath, Dagmar Stoiber, Tim I. Malcolm, Suzanne D. Turner, Eileen E. Parkes, Brigitte Hantusch, Gerda Egger, Stefan Rose-John, Valeria Poli, Suneil Jain, Chris W. D. Armstrong, Gregor Hoermann, Vincent Goffin, Fritz Aberger, Richard Moriggl, Arkaitz Carracedo, Cathal McKinney, Richard D. Kennedy, Helmut Klocker, Michael R. Speicher, Dean G. Tang, Ali A. Moazzami, David M. Heery, Marcus Hacker, Lukas Kenner

Summary: PTEN and STAT3 are frequently co-deleted genes in metastatic prostate cancer (mPCa). STAT3 controls mPCa through the LKB1/pAMPK/mTORC1/CREB signaling pathway, and metformin can inhibit mPCa growth.

MOLECULAR CANCER (2023)

Article Biochemistry & Molecular Biology

METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

Raquel Garcia-Vilchez, Ana M. M. Anazco-Guenkova, Sabine Dietmann, Judith Lopez, Virginia Moron-Calvente, Silvia D'Ambrosi, Paz Nombela, Kepa Zamacola, Isabel Mendizabal, Saioa Garcia-Longarte, Amaia Zabala-Letona, Ianire Astobiza, Sonia Fernandez, Alejandro Paniagua, Borja Miguel-Lopez, Virginie Marchand, Diego Alonso-Lopez, Angelika Merkel, Ignacio Garcia-Tunon, Aitziber Ugalde-Olano, Ana Loizaga-Iriarte, Isabel Lacasa-Viscasillas, Miguel Unda, Mikel Azkargorta, Felix Elortza, Laura Barcena, Monika Gonzalez-Lopez, Ana M. M. Aransay, Tomas Di Domenico, Manuel A. A. Sanchez-Martin, Javier De Las Rivas, Sonia Guil, Yuri Motorin, Mark Helm, Pier Paolo Pandolfi, Arkaitz Carracedo, Sandra Blanco

Summary: New evidence suggests that epitranscriptomic marks play an important role in cancer development, but the role and implications of altered epitranscriptome deposition in prostate cancer are largely unknown. This study demonstrates that the transfer RNA N-7-methylguanosine (m(7)G) transferase METTL1 is highly expressed in prostate tumors and its depletion leads to the loss of m(7)G tRNA methylation and the formation of small non-coding RNAs derived from 5'tRNA fragments. These small RNAs regulate translation control and favor the synthesis of key regulators and immune effectors, impacting tumor growth suppression and response to immunotherapy in prostate cancer models.

MOLECULAR CANCER (2023)

Article Cell Biology

FOXA2 controls the anti-oxidant response in FH-deficient cells

Connor Rogerson, Marco Sciacovelli, Lucas A. Maddalena, Andromachi Pouikli, Marc Segarra-Mondejar, Lorea Valcarcel-Jimenez, Christina Schmidt, Ming Yang, Elena Ivanova, Joshua Kent, Ariane Mora, Danya Cheeseman, Jason S. Carroll, Gavin Kelsey, Christian Frezza

Summary: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a cancer syndrome caused by inactivating germ-line mutations in fumarate hydratase (FH) and subsequent accumulation of fumarate. Fumarate accumulation leads to profound epigenetic changes and the activation of an antioxidant response via nuclear translocation of the transcription factor NRF2. The identification of FOXA2 as an antioxidant regulator provides additional insights into the molecular mechanisms behind cell responses to fumarate accumulation and potentially provides further avenues for therapeutic intervention for HLRCC.

CELL REPORTS (2023)

Review Oncology

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications

Nadia Saoudi Gonzalez, Francesc Salva, Javier Ros, Iosune Baraibar, Marta Rodriguez-Castells, Ariadna Garcia, Adriana Alcaraz, Sharela Vega, Sergio Bueno, Josep Tabernero, Elena Elez

Summary: Metastatic colorectal cancer is a complex and life-threatening disease influenced by various factors. Tumor heterogeneity, caused by genetic and non-genetic factors, affects tumor development and therapy effectiveness. Computational analysis of next-generation sequencing and real-time monitoring of circulating tumor DNA are valuable tools in understanding tumor evolution and heterogeneity.

CANCERS (2023)

Article Medicine, Research & Experimental

Factor-inhibiting HIF (FIH) promotes lung cancer

Ana Garcia-del Rio, Endika Prieto-Fernandez, Leire Egia-Mendikute, Asier Antonana-Vildosola, Borja Jimenez-Lasheras, So Young Lee, Adrian Barreira-Manrique, Samanta Romina Zanetti, Ander de Blas, Paloma Velasco-Beltran, Alexandre Bosch, Ana M. Aransay, Asis Palazon

Summary: Factor-inhibiting HIF (FIH) is an asparagine hydroxylase expressed in tumors, and its deletion may lead to increased metabolism, decreased proliferation, and increased immune infiltration in cancer cells.

JCI INSIGHT (2023)

Meeting Abstract Gastroenterology & Hepatology

The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH

Maider Apodaka-Biguri, Francisco Gonzalez-Romero, Andre L. Simao, Daniela Mestre Congregado, Igor Aurrekoetxea, Beatriz Gomez Santos, Igotz Delgado, Xabier Buque, Ane Nieva-Zuluaga, Mikel Ruiz de Gauna, Idoia Fernandez-Puertas, Ainhoa Iglesias, Ana Maria Aransay, Juanjo Lozano, Cesar Augusto Martin, Irantzu Bernales, Pedro Miguel Rodrigues, Jesus Maria Banales, Ana Zubiaga, Rui E. Castro, Patricia Aspichueta

JOURNAL OF HEPATOLOGY (2023)

Article Biochemical Research Methods

An aggregation-induced emission-based ratiometric fluorescent chemosensor for Hg(II) and its application in Caenorhabditis elegans imaging

K. Ramki, G. Thiruppathi, Selva Kumar Ramasamy, P. Sundararaj, P. Sakthivel

Summary: A chromone-based ratiometric fluorescent probe L2 was developed for the selective detection of Hg(II) in a semiaqueous solution. The probe exhibited enhanced fluorescence in its aggregated state and even higher fluorescence when chelated with Hg(II). The probe demonstrated high sensitivity and specificity for Hg(II) detection and was successfully applied for imaging Hg(II) in a living model.

METHODS (2024)

Article Biochemical Research Methods

Smartphone-based low-cost and rapid quantitative detection of urinary creatinine with the Tyndall effect

Qun Zhang, Rui Yang, Gang Liu, Shiyan Jiang, Jiarui Wang, Juqiang Lin, Tingyin Wang, Jing Wang, Zufang Huang

Summary: This research aims to develop a cost-effective and portable method for measuring creatinine levels using the enhanced Tyndall effect phenomenon. The method offers a promising solution for monitoring renal healthcare in resource-limited settings.

METHODS (2024)